Clal Insurance’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$81M Sell
88,051
-9,994
-10% -$10.1M 0.49% 45
2025
Q4
$105M Sell
98,045
-39,034
-28% -$37.3M 0.68% 35
2025
Q3
$105M Buy
137,079
+50,509
+58% +$37.6M 0.8% 34
2025
Q2
$67.5M Buy
86,570
+515
+0.6% +$400K 0.66% 39
2025
Q1
$71.1M Sell
86,055
-3,649
-4% -$3.04M 0.74% 35
2024
Q4
$69.3M Buy
89,704
+4,904
+6% +$4.06M 0.62% 36
2024
Q3
$75.1M Buy
84,800
+13,200
+18% +$11.9M 0.66% 39
2024
Q2
$64.8M Sell
71,600
-1,700
-2% -$1.36M 0.68% 36
2024
Q1
$57M Sell
73,300
-1,200
-2% -$854K 0.64% 40
2023
Q4
$43.4M Buy
74,500
+73,500
+7,350% +$42.9M 0.57% 47
2023
Q3
$537K Sell
1,000
-1,000
-50% -$515K 0.01% 105
2023
Q2
$938K Sell
2,000
-500
-20% -$210K 0.01% 111
2023
Q1
$859K Buy
+2,500
New +$843K 0.01% 117

Other funds holding LLY